AQR Capital Management LLC raised its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 11.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 211,644 shares of the specialty chemicals company's stock after acquiring an additional 22,566 shares during the quarter. AQR Capital Management LLC owned approximately 0.38% of Cabot worth $19,448,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of CBT. UBS Group AG lifted its holdings in shares of Cabot by 51.1% during the 4th quarter. UBS Group AG now owns 83,355 shares of the specialty chemicals company's stock valued at $6,960,000 after buying an additional 28,204 shares during the last quarter. TFO Wealth Partners LLC lifted its holdings in shares of Cabot by 63,400.0% during the 4th quarter. TFO Wealth Partners LLC now owns 1,905 shares of the specialty chemicals company's stock valued at $159,000 after buying an additional 1,902 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Cabot during the 4th quarter valued at about $1,062,000. Quadrature Capital Ltd lifted its holdings in shares of Cabot by 267.3% during the 4th quarter. Quadrature Capital Ltd now owns 11,380 shares of the specialty chemicals company's stock valued at $950,000 after buying an additional 8,282 shares during the last quarter. Finally, Personal CFO Solutions LLC lifted its holdings in shares of Cabot by 17.4% during the 4th quarter. Personal CFO Solutions LLC now owns 4,266 shares of the specialty chemicals company's stock valued at $356,000 after buying an additional 633 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on CBT shares. JPMorgan Chase & Co. lifted their price target on Cabot from $95.00 to $105.00 and gave the company a "neutral" rating in a report on Wednesday, August 7th. StockNews.com lowered Cabot from a "strong-buy" rating to a "buy" rating in a report on Monday, June 24th. Finally, UBS Group reduced their target price on Cabot from $103.00 to $98.00 and set a "neutral" rating for the company in a report on Tuesday, August 6th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $101.75.
View Our Latest Report on Cabot
Cabot Stock Performance
CBT traded down $0.90 on Tuesday, hitting $110.87. The company had a trading volume of 167,970 shares, compared to its average volume of 342,688. The company's fifty day moving average price is $101.93 and its 200 day moving average price is $97.81. Cabot Co. has a 1-year low of $65.10 and a 1-year high of $113.12. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.22 and a quick ratio of 1.45. The stock has a market cap of $6.13 billion, a price-to-earnings ratio of 14.03, a price-to-earnings-growth ratio of 1.01 and a beta of 1.19.
Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1 billion. During the same period in the previous year, the company earned $1.42 EPS. The company's revenue for the quarter was up 5.0% on a year-over-year basis. Equities analysts predict that Cabot Co. will post 7.07 earnings per share for the current fiscal year.
Cabot Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Friday, August 30th were issued a dividend of $0.43 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.55%. Cabot's dividend payout ratio (DPR) is presently 21.77%.
Insider Transactions at Cabot
In other news, CFO Erica Mclaughlin sold 23,274 shares of the company's stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at $5,968,839.06. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Sean D. Keohane sold 25,617 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the sale, the chief executive officer now directly owns 331,174 shares in the company, valued at $33,630,719.70. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Erica Mclaughlin sold 23,274 shares of the business's stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now owns 59,814 shares in the company, valued at $5,968,839.06. The disclosure for this sale can be found here. Insiders sold a total of 71,939 shares of company stock worth $7,308,812 over the last three months. 3.07% of the stock is currently owned by insiders.
About Cabot
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report